1. Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2013; 99: 63 [
DOI:10.1016/j.fertnstert.2012.09.023]
2. Baek KH, Lee EJ, Kim YS. Recurrent pregnancy loss: the key potential mechanisms. Trends Mol Med 2007; 13: 310-317. [
DOI:10.1016/j.molmed.2007.05.005]
3. Patriarca A, Piccioni V, Gigante V, Benedetto C. The use of intravenous immunoglobulin in sine causa or alloimmune recurrent spontaneous abortion (RSA). Panminerva Med 2000; 42: 193-195.
4. Jeve YB, Davies W. Evidence-based management of recurrent miscarriages. J Hum Reprod Sci 2014; 7: 159-169. [
DOI:10.4103/0974-1208.142475]
5. Zhang B, Wang Q, Wang K, Pan X, Liu F, Guo T, et al. Identification of cotton microRNAs and their targets. Gene 2007; 397: 26-37. [
DOI:10.1016/j.gene.2007.03.020]
6. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233. [
DOI:10.1016/j.cell.2009.01.002]
7. McCallie B, Schoolcraft WB, Katz-Jaffe MG. Aberration of blastocyst microRNA expression is associated with human infertility. Fertil Steril 2010; 93: 2374-2382. [
DOI:10.1016/j.fertnstert.2009.01.069]
8. Jeon YJ, Choi YS, Rah H, Kim SY, Choi DH, Cha SH, et al. Association study of microRNA polymorphisms with risk of idiopathic recurrent spontaneous abortion in Korean women. Gene 2012; 494: 168-173. [
DOI:10.1016/j.gene.2011.12.026]
9. Qin W, Tang Y, Yang N, Wei X, Wu J. Potential role of circulating microRNAs as a biomarker for unexplained recurrent spontaneous abortion. Fertil Steril 2016; 105: 1247-1254. [
DOI:10.1016/j.fertnstert.2016.01.028]
10. Papazoglou D, Galazios G, Papatheodorou K, Liberis V, Papanas N, Maltezos E, et al. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil Steril 2005; 83: 959-963. [
DOI:10.1016/j.fertnstert.2004.12.017]
11. Plaisier M. Decidualisation and angiogenesis. Best Prac Res Clin Obstet Gynaecol 2011; 25: 259-271. [
DOI:10.1016/j.bpobgyn.2010.10.011]
12. Murray MJ, Lessey BA, Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis. Semin Reprod Endocrinol 1999; 17: 275-290. [
DOI:10.1055/s-2007-1016235]
13. Choi HK, Choi BC, Lee SH, Kim JW, Cha KY, Baek KH. Expression of angiogenesis-and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev 2003; 66: 24-31. [
DOI:10.1002/mrd.10331]
14. Charnock-Jones D, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004; 25: 103-113. [
DOI:10.1016/j.placenta.2003.10.004]
15. Hassan MF. Soluble fms-like tyrosine kinase-1 and vascular endothelial growth factor: Novel markers for unexplained early recurrent pregnancy loss. Asian Pac J Reprod 2014; 3: 30-34. [
DOI:10.1016/S2305-0500(13)60181-5]
16. Zhu Y, Lu H, Huo Z, Ma Z, Dang J, Dang W, et al. MicroRNA-16 inhibits feto-maternal angiogenesis and causes recurrent spontaneous abortion by targeting vascular endothelial growth factor. Sci Rep 2016; 6: 35536. [
DOI:10.1038/srep35536]
17. Liu LZ, Li C, Chen Q, Jing Y, Carpenter R, Jiang Y, et al. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression. PloS One 2011; 6: e19139. [
DOI:10.1371/journal.pone.0019139]
18. Amirchaghmaghi E, Rezaei A, Moini A, Roghaei MA, Hafezi M, Aflatoonian R. Gene expression analysis of VEGF and its receptors and assessment of its serum level in unexplained recurrent spontaneous abortion. Cell J 2015; 16: 538-545.
19. Tokyol C, Aktepe F, Husniye Dilek F, Yilmazer M. Comparison of placental PTEN and β1 integrin expression in early spontaneous abortion, early and late normal pregnancy. Ups J Med Sci 2008; 113: 235-242. [
DOI:10.3109/2000-1967-231]
20. El-Shorafa HM, Sharif FA. Dysregulation of micro-RNA contributes to the risk of unexplained recurrent pregnancy loss. Int J Reprod Contracep Obstet Gynecol 2013; 2: 330-335. [
DOI:10.5455/2320-1770.ijrcog20130914]
21. Ma Y, Zhang P, Wang F, Yang J, Yang Z, Qin H. The relationship between early embryo development and tumourigenesis. J Cel Mol Med 2010; 14: 2697-2770. [
DOI:10.1111/j.1582-4934.2010.01191.x]
22. Holtan SG, Creedon DJ, Haluska P, Markovic SN, Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc 2009; 84: 985-1000. [
DOI:10.1016/S0025-6196(11)60669-1]
23. Vuorela P, Carpén O, Tulppala M, Halmesmäki E. VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod 2000; 6: 276-282. [
DOI:10.1093/molehr/6.3.276]